What if you'd held CRMD?
A $1,000 investment in CorMedix Inc. (CRMD) at the month-end close of 2010-05 would be worth $622 at the close of 2026-09 — -37.8% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $9,557.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2010
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2010 | $1,000 | — |
| 2011 | $154 | -84.6% |
| 2012 | $396 | +157.1% |
| 2013 | $681 | +72.2% |
| 2014 | $1,049 | +54.0% |
| 2015 | $1,115 | +6.3% |
| 2016 | $841 | -24.6% |
| 2017 | $275 | -67.3% |
| 2018 | $709 | +158.0% |
| 2019 | $800 | +12.9% |
| 2020 | $816 | +2.1% |
| 2021 | $500 | -38.8% |
| 2022 | $464 | -7.3% |
| 2023 | $413 | -10.9% |
| 2024 | $890 | +115.4% |
| 2025 | $1,278 | +43.6% |
| 2026 | $926 | -27.5% |
Best and worst month-end to buy
The best single month-end close to have bought CRMD was 2012-08 ($0.90): $1,000 then is $9,367 today. The worst was 2015-03 ($49.20): $1,000 then is $171.
FAQ
What would $1,000 in CRMD be worth today?
A $1,000 investment in CorMedix Inc. (CRMD) at the start of 2010 would be worth about $622 today, a total return of -37.8%. Dividends are reinvested in these figures.
What were the best and worst years for CRMD?
CorMedix Inc. (CRMD)'s strongest calendar year since 2010 was 2018, a +158.0% return — $1,000 held through that year became about $2,580 by year-end. Its weakest year was 2011, at -84.6%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in CRMD have grown?
Investing $100 at the end of every month since 2010-05 would have grown to about $37,479 on $19,700 invested.
Did CRMD beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $9,557. CRMD trailed the S&P 500 by +93.5% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
CorMedix Inc. (CRMD) historical total-return data from 2010-05 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.